☰

Lihui Lu - Publications

Affiliations: 
University of California, Berkeley, Berkeley, CA, United States 
Area:
Visual system
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lu L, Li W, Cheng Y, Liu M. Chemical recycling technologies for PVC waste and PVC-containing plastic waste: A review. Waste Management (New York, N.Y.). 166: 245-258. PMID 37196390 DOI: 10.1016/j.wasman.2023.05.012  0.623
2022 Li W, Lu L, Cheng C, Ren N, Yang ST, Liu M. Biohydrogen production from brown algae fermentation: Relationship between substrate reduction degree and hydrogen production. Bioresource Technology. 364: 128069. PMID 36208827 DOI: 10.1016/j.biortech.2022.128069  0.617
2022 Ma L, Wang J, Zhang Y, Fang F, Ling J, Chu X, Zhang Z, Tao Y, Li X, Tian Y, Li Z, Sang X, Zhang K, Lu L, Wan X, et al. BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes. Cancer Biology & Therapy. 23: 1-15. PMID 36170346 DOI: 10.1080/15384047.2022.2125748  0.683
2022 Sang X, Zhang Y, Fang F, Gao L, Tao Y, Li X, Zhang Z, Wang J, Tian Y, Li Z, Yao D, Wu Y, Chu X, Zhang K, Ma L, ... Lu L, et al. BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia. Journal of Immunology Research. 2022: 7912484. PMID 35958877 DOI: 10.1155/2022/7912484  0.663
2022 Zhang K, Gao L, Wang J, Chu X, Zhang Z, Zhang Y, Fang F, Tao Y, Li X, Tian Y, Li Z, Sang X, Ma L, Lu L, Chen Y, et al. A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells. Pathology Oncology Research : Por. 28: 1610447. PMID 35832114 DOI: 10.3389/pore.2022.1610447  0.666
2022 Zhang R, Lu L, Chang Y, Liu M. Gas sensing based on metal-organic frameworks: Concepts, functions, and developments. Journal of Hazardous Materials. 429: 128321. PMID 35236036 DOI: 10.1016/j.jhazmat.2022.128321  0.628
2022 Li L, Lu L, Ren Y, Tang G, Zhao Y, Cai X, Shi Z, Ding H, Liu C, Cheng D, Xie Y, Wang H, Fu X, Yin L, Luo M, et al. Colocalized, bidirectional optogenetic modulations in freely behaving mice with a wireless dual-color optoelectronic probe. Nature Communications. 13: 839. PMID 35149715 DOI: 10.1038/s41467-022-28539-7  0.705
2021 Hsieh MT, Lu LH, Lin CW, Chen YW. Correlation Between Malpractice Litigation and Legislation Reform in Taiwan Over a 30-Year Period. International Journal of General Medicine. 14: 1889-1898. PMID 34040421 DOI: 10.2147/IJGM.S312640  0.6
2021 Zhou M, Guo L, Li Y, Lu LH, Chang Y, Wang WP, Li X, Xu XR, Gao JZ. [Expression and Significance of Low-Density Lipoprotein-Related Receptors 5 and 6 in the Wnt/β-Catenin Signaling Pathway in Childhood Acute Lymphoblastic Leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 29: 433-438. PMID 33812411 DOI: 10.19746/j.cnki.issn.1009-2137.2021.02.020  0.625
2020 Lu L, Wang R, Luo M. An optical brain-to-brain interface supports rapid information transmission for precise locomotion control. Science China. Life Sciences. PMID 32266609 DOI: 10.1007/S11427-020-1675-X  0.684
2020 Lu L, Ren Y, Yu T, Liu Z, Wang S, Tan L, Zeng J, Feng Q, Lin R, Liu Y, Guo Q, Luo M. Control of locomotor speed, arousal, and hippocampal theta rhythms by the nucleus incertus. Nature Communications. 11: 262. PMID 31937768 DOI: 10.1038/S41467-019-14116-Y  0.727
2019 Lu L, Kumagai S, Kameda T, Luo L, Yoshioka T. Degradation of PVC waste into a flexible polymer by chemical modification using DINP moieties. Rsc Advances. 9: 28870-28875. PMID 35529626 DOI: 10.1039/c9ra05081g  0.72
2019 Wang WP, Guo L, Li Y, Lu LH, Chang Y, Zhou B, Zhou M, Li X, Gao JZ. [Expression and significance of dishevelled proteins in the Wnt pathway in childhood acute lymphoblastic leukemia]. Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics. 21: 411-414. PMID 31104653 DOI: 10.7499/j.issn.1008-8830.2019.05.002  0.632
2018 Ding H, Lu L, Shi Z, Wang D, Li L, Li X, Ren Y, Liu C, Cheng D, Kim H, Giebink NC, Wang X, Yin L, Zhao L, Luo M, et al. Microscale optoelectronic infrared-to-visible upconversion devices and their use as injectable light sources. Proceedings of the National Academy of Sciences of the United States of America. PMID 29891705 DOI: 10.1073/Pnas.1802064115  0.686
2018 Liu Q, Lü L, Sun H, Zhang J, Ma W, Zhang T. [Effect of serum on the differentiation of neural stem cells]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery. 32: 223-227. PMID 29806416 DOI: 10.7507/1002-1892.201710113  0.62
2016 Wu S, Lu L, Zhao M, Wu W, Fu H, Liu X. [Study on Potential Role of Calreticulin in Pressure Overload Induced Cardiac Hypertrophy]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 33: 512-9. PMID 29709152  0.651
2016 Ott GR, Cheng M, Learn KS, Wagner J, Gingrich DE, Lisko JG, Curry M, Mesaros EF, Ghose AK, Quail MR, Wan W, Lu L, Dobrzanski P, Albom MS, Angeles TS, et al. Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK). Journal of Medicinal Chemistry. PMID 27527804 DOI: 10.1021/acs.jmedchem.6b00487  0.675
2016 Zhao M, Lu L, Lei S, Chai H, Wu S, Tang X, Bao Q, Chen L, Wu W, Liu X. Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid. Oxidative Medicine and Cellular Longevity. 2016: 1451676. PMID 27057269 DOI: 10.1155/2016/1451676  0.662
2015 Lü LH, Liu WQ, Zhang TS, Lu YH, Dong YS, Chen ZY, Fan GQ, Qi SS. [Two Data Inversion Algorithms of Aerosol Horizontal Distributiol Detected by MPL and Error Analysis]. Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu. 35: 1774-8. PMID 26717723  0.612
2015 Zhao M, Qin Y, Lu L, Tang X, Wu W, Fu H, Liu X. [Preliminary Study of Necroptosis in Cardiac Hypertrophy Induced by Pressure Overload]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 32: 618-23. PMID 26485988  0.643
2015 Lu L, Zhao M, Wu S, Wu W, Fu H, Liu X. [Effects of Inhibiting Necroptosis on H9c2 Cardiomyocytes Injury Induced by Hypoxia/Reoxygenation]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 32: 393-9. PMID 26211260  0.642
2015 Mesaros EF, Angeles TS, Albom MS, Wagner JC, Aimone LD, Wan W, Lu L, Huang Z, Olsen M, Kordwitz E, Haltiwanger RC, Landis AJ, Cheng M, Ruggeri BA, Ator MA, et al. Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase. Bioorganic & Medicinal Chemistry Letters. 25: 1047-52. PMID 25655723 DOI: 10.1016/j.bmcl.2015.01.019  0.68
2014 Li J, Liao Y, Lu L, Lu L, Feng J, Wu W, Liu X. [Preliminary investigation into the mechanism of cardiomyocyte hypertrophy induced by visfatin]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 31: 379-84. PMID 25039146  0.662
2013 Zhao ZG, Liao YB, Peng Y, Chai H, Liu W, Li Q, Ren X, Wang XQ, Luo XL, Zhang C, Lu LH, Meng QT, Chen C, Chen M, Feng Y, et al. Sex-related differences in outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis. Circulation. Cardiovascular Interventions. 6: 543-51. PMID 24065446 DOI: 10.1161/CIRCINTERVENTIONS.113.000529  0.606
2013 Qian J, Lu L, Wu J, Ma H. Development of multiple cell-based assays for the detection of histone H3 Lys27 trimethylation (H3K27me3). Assay and Drug Development Technologies. 11: 449-56. PMID 23992119 DOI: 10.1089/adt.2013.515  0.654
2012 Zhang T, Lu LH, Liu H, Wang JW, Wang RX, Zhang YX, Tao JC. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation. Bioorganic & Medicinal Chemistry Letters. 22: 5827-32. PMID 22901386 DOI: 10.1016/j.bmcl.2012.07.083  0.646
2012 Gingrich DE, Lisko JG, Curry MA, Cheng M, Quail M, Lu L, Wan W, Albom MS, Angeles TS, Aimone LD, Haltiwanger RC, Wells-Knecht K, Ott GR, Ghose AK, Ator MA, et al. Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase. Journal of Medicinal Chemistry. 55: 4580-93. PMID 22564207 DOI: 10.1021/jm201550q  0.686
2012 Cheng M, Quail MR, Gingrich DE, Ott GR, Lu L, Wan W, Albom MS, Angeles TS, Aimone LD, Cristofani F, Machiorlatti R, Abele C, Ator MA, Dorsey BD, Inghirami G, et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Molecular Cancer Therapeutics. 11: 670-9. PMID 22203728 DOI: 10.1158/1535-7163.MCT-11-0776  0.676
2012 Mesaros EF, Thieu TV, Wells GJ, Zificsak CA, Wagner JC, Breslin HJ, Tripathy R, Diebold JL, McHugh RJ, Wohler AT, Quail MR, Wan W, Lu L, Huang Z, Albom MS, et al. Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitors. Journal of Medicinal Chemistry. 55: 115-25. PMID 22141319 DOI: 10.1021/jm2010767  0.671
2011 Ott GR, Wells GJ, Thieu TV, Quail MR, Lisko JG, Mesaros EF, Gingrich DE, Ghose AK, Wan W, Lu L, Cheng M, Albom MS, Angeles TS, Huang Z, Aimone LD, et al. 2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity. Journal of Medicinal Chemistry. 54: 6328-41. PMID 21859094 DOI: 10.1021/jm200758k  0.682
2011 Mesaros EF, Burke JP, Parrish JD, Dugan BJ, Anzalone AV, Angeles TS, Albom MS, Aimone LD, Quail MR, Wan W, Lu L, Huang Z, Ator MA, Ruggeri BA, Cheng M, et al. Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models. Bioorganic & Medicinal Chemistry Letters. 21: 463-6. PMID 21074994 DOI: 10.1016/j.bmcl.2010.10.115  0.674
2010 Ott GR, Tripathy R, Cheng M, McHugh R, Anzalone AV, Underiner TL, Curry MA, Quail MR, Lu L, Wan W, Angeles TS, Albom MS, Aimone LD, Ator MA, Ruggeri BA, et al. Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity. Acs Medicinal Chemistry Letters. 1: 493-8. PMID 24900237 DOI: 10.1021/ml100158s  0.699
2009 Lu L, Ghose AK, Quail MR, Albom MS, Durkin JT, Holskin BP, Angeles TS, Meyer SL, Ruggeri BA, Cheng M. ALK mutants in the kinase domain exhibit altered kinase activity and differential sensitivity to small molecule ALK inhibitors. Biochemistry. 48: 3600-9. PMID 19249873 DOI: 10.1021/bi8020923  0.689
2006 Wan W, Albom MS, Lu L, Quail MR, Becknell NC, Weinberg LR, Reddy DR, Holskin BP, Angeles TS, Underiner TL, Meyer SL, Hudkins RL, Dorsey BD, Ator MA, Ruggeri BA, et al. Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells. Blood. 107: 1617-23. PMID 16254137 DOI: 10.1182/blood-2005-08-3254  0.661
Show low-probability matches.